Amedisys Profit Margin 2010-2024 | AMED

Current and historical gross margin, operating margin and net profit margin for Amedisys (AMED) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Amedisys net profit margin as of June 30, 2024 is 4.02%.
Amedisys Annual Profit Margins
Amedisys Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.164B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.044B 12.73
Quest Diagnostics (DGX) United States $17.232B 17.67
DaVita (DVA) United States $13.682B 16.83
Encompass Health (EHC) United States $9.661B 23.76
Chemed (CHE) United States $9.016B 27.72
Elanco Animal Health (ELAN) United States $7.079B 15.91
Option Care Health (OPCH) United States $5.374B 26.40
RadNet (RDNT) United States $5.127B 121.63
Astrana Health (ASTH) United States $2.775B 39.26
LifeStance Health (LFST) United States $2.655B 0.00
Addus HomeCare (ADUS) United States $2.370B 28.78
U.S Physical Therapy (USPH) United States $1.272B 34.44
Pennant (PNTG) United States $1.039B 49.84
Aveanna Healthcare Holdings (AVAH) United States $0.999B 0.00
Atai Life Sciences (ATAI) Germany $0.196B 0.00
Daxor (DXR) United States $0.043B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.008B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00